WO2023249065A1 - 組織再生促進シート - Google Patents
組織再生促進シート Download PDFInfo
- Publication number
- WO2023249065A1 WO2023249065A1 PCT/JP2023/022993 JP2023022993W WO2023249065A1 WO 2023249065 A1 WO2023249065 A1 WO 2023249065A1 JP 2023022993 W JP2023022993 W JP 2023022993W WO 2023249065 A1 WO2023249065 A1 WO 2023249065A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sheet
- nonwoven fabric
- tissue regeneration
- stem cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
- C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/02—Membranes; Filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/72—Chitin, chitosan
Definitions
- the present invention relates to a tissue regeneration promoting sheet.
- Patent Document 1 discloses a sheet-like tissue regeneration promoting material on the surface of which at least one of the group consisting of leukocytes and platelets is present.
- Patent Document 2 discloses a liquid tissue regeneration promoting material obtained by mixing powder of a polymer material and cells.
- tissue regeneration promoting materials disclosed in Patent Documents 1 and 2 use powders of porous materials and polymeric materials, so that mesenchymal stem cells, which have high tissue regeneration ability among cells, are stably retained.
- the problem is that it is difficult.
- Such problems exist not only when mesenchymal stem cells are retained using tissue regeneration promoting materials, but also when other stem cells are retained.
- the present invention was made based on this background, and an object of the present invention is to provide a tissue regeneration promoting sheet that is capable of stably retaining stem cells.
- the tissue regeneration promoting sheet includes a nonwoven fabric that contains fibers whose main component is polycaprolactone and is capable of permeating a cell suspension containing stem cells.
- the fiber diameter of the fibers constituting the nonwoven fabric may be within the range of 300 nm to 2 ⁇ m.
- the basis weight of the nonwoven fabric may be within the range of 1 g/m 2 to 3 g/m 2 .
- the thickness of the nonwoven fabric may be 300 ⁇ m or more.
- the tissue regeneration promoting sheet may further include a reinforcing sheet that is laminated on the nonwoven fabric and is capable of permeating the cell suspension.
- the reinforcing sheet may be another nonwoven fabric made of fibers that are thicker than the fibers that make up the nonwoven fabric.
- the nonwoven fabric may include a first nonwoven fabric and a second nonwoven fabric that is laminated on the first nonwoven fabric and is less deformable than the first nonwoven fabric.
- tissue regeneration promoting sheet capable of stably retaining stem cells.
- FIG. 1 is a perspective view showing the structure of a tissue regeneration promoting sheet according to an embodiment of the present invention.
- FIG. 1 is a front view showing how a tissue regeneration promoting sheet according to an embodiment of the present invention is manufactured. It is a perspective view showing the composition of a tissue regeneration promotion sheet concerning a modification of the present invention.
- FIG. 3 is a perspective view showing the structure of a tissue regeneration promoting sheet according to another modification of the present invention.
- 3 is a diagram showing the capture rate of mesenchymal stem cells by each sample in Example 1.
- FIG. 3 is a diagram showing the capture rate of mesenchymal stem cells by each sample in Example 2.
- FIG. 3 is a diagram showing a CT image of a rat cervical vertebrae in Example 3.
- FIG. FIG. 6 is a diagram showing an immunostaining image 6 weeks after bone transplantation in Example 3.
- the tissue regeneration promoting sheet according to the embodiment is a sheet that promotes tissue regeneration at the damaged site by being embedded in the damaged site within the body.
- the tissue regeneration promoting sheet according to the embodiment includes a nonwoven fabric made of small diameter fibers, such as microfibers, to which stem cells are attached.
- a nonwoven fabric is a sheet made of fine fibers that are intertwined without being woven. Nonwoven fabrics can be freely deformed, so they are suitable for embedding or pasting in accordance with the shape of the damaged area.
- the tissue regeneration promoting sheet can be attached to or embedded in any organ or organ, such as the heart, blood vessels, lungs, trachea, esophagus, stomach, small intestine, large intestine, liver, kidney, bladder, bone, muscle, or skin.
- the tissue regeneration promoting sheet can function as a scaffold that promotes the proliferation of specific cells in the body.
- the tissue regeneration promoting sheet 10 includes a cell retaining sheet 12 that retains stem cells, and a pair of reinforcing sheets 14 that are joined to sandwich the cell retaining sheet 12 from above and below and reinforcing the cell retaining sheet 12. , is provided.
- the reason why the cell retention sheet 12 is reinforced by sandwiching it between a pair of reinforcing sheets 14 is that the nonwoven fabric constituting the cell retention sheet 12 tends to curl up easily when wet due to the properties of the raw materials described below.
- the cell holding sheet 12 and the reinforcing sheet 14 may be joined to each other by adhesive or thermal fusion, or may be joined by intertwining the fibers during production of the nonwoven fabric.
- the number of cell holding sheets 12 arranged between the pair of reinforcing sheets 14 is arbitrary within the range that can filter the cell suspension containing stem cells, but when filtering the cell suspension, In order to prevent the cell suspension from leaking, it is preferable to laminate two or more layers.
- a cell suspension is a liquid in which cells are suspended in a liquid that can be administered into the body.
- a plurality of cell retention sheets 12 are stacked, they may be joined together using the same method as in the case of stacking the cell retention sheets 12 and reinforcing sheets 14.
- the thickness direction of the tissue regeneration promoting sheet 10 is exaggerated for ease of understanding. The thickness of the tissue regeneration promoting sheet 10 is set to such an extent that the cell suspension can be filtered.
- the cell holding sheet 12 is a nonwoven fabric containing fibers whose main component is polycaprolactone.
- a nonwoven fabric containing fibers mainly composed of polycaprolactone can capture stem cells with high efficiency when a cell suspension containing stem cells is filtered, and also promotes the activity of attached stem cells. I found that it can be done.
- Polycaprolactone is a semi-crystalline, biodegradable thermoplastic polyester and is also suitable for the production of nonwoven fabrics.
- Polycaprolactone is, for example, poly- ⁇ -caprolactone.
- the molecular weight of polycaprolactone may be a molecular weight suitable for injection molding, for example within the range of 70,000 to 100,000.
- the fiber whose main component is polycaprolactone may be formed only from polycaprolactone or may contain other substances.
- Other substances may include, for example, agents that promote tissue regeneration and other biodegradable polymers.
- Agents that promote tissue regeneration include, for example, hydroxyapatite (calcium phosphate hydroxide) and tricalcium phosphate.
- Other biodegradable polymers are, for example, polylactic acid, polyglycolic acid, polydioxanone, and copolymers thereof.
- the fiber diameter of the fibers constituting the cell holding sheet 12 is, for example, in the range of 100 nm to 3 ⁇ m, and preferably in the range of 500 nm to 1 ⁇ m, taking into account the capture rate and handling properties of stem cells.
- the basis weight of the cell holding sheet 12 is, for example, within the range of 1 g/m 2 to 3 g/m 2 , and 1.5 g/m 2 to 2.0 g/m 2 , taking into account the amount of stem cells attached and ease of production. It is preferably within the range of 5 g/m 2 , more preferably 2 g/m 2 .
- the thickness of the cell holding sheet 12 is preferably, for example, 300 ⁇ m or more, and more preferably 500 ⁇ m or more, in consideration of handling properties with tweezers. However, it should be noted that the thicker the cell holding sheet 12 becomes, the more difficult it becomes to filter the cell suspension.
- the stem cells attached to the cell holding sheet 12 are preferably mesenchymal stem cells (MSCs) or cells differentiated from mesenchymal stem cells.
- MSCs mesenchymal stem cells
- Mesenchymal stem cells are somatic stem cells that have the ability to differentiate into cells belonging to the mesenchymal system, and are derived from fat, periosteum, synovium, cancellous bone, bone marrow, amniotic membrane, cord blood, and placenta. It may be either.
- the stem cells attached to the nonwoven fabric may be, for example, ES (Embryonic Stem) cells or iPS (Induced Pluripotent Stem) cells. Multiple types of stem cells may be attached to the nonwoven fabric together.
- the stem cells to be attached to the cell holding sheet 12 are preferably collected from a patient and cultured.
- a medium containing fetal bovine serum (FBS) or human serum, preferably patient-derived human serum, or a serum-free medium may be used.
- FBS fetal bovine serum
- human serum preferably patient-derived human serum
- serum-free medium preferably serum-free medium.
- Stem cells cultured in a medium may be directly attached to the nonwoven fabric, or the stem cells may be differentiated to express specific cells, such as osteoblasts, and then attached to the nonwoven fabric.
- a differentiation-inducing factor may be added to the stem cell culture medium.
- the cell suspension containing stem cells may be administered to the vascular system after the tissue regeneration promoting sheet 10 is placed at the damaged site in the body. Then, the stem cells may be captured by the cell holding sheet 12 in the body.
- the reinforcing sheet 14 is a nonwoven fabric that includes fibers whose main component is a biocompatible polymer and allows the cell suspension to pass therethrough.
- the reinforcing sheet 14 is joined to the cell holding sheet 12 in order to reinforce the cell holding sheet 12, which tends to curl up and deform easily.
- the biocompatible polymer constituting the reinforcing sheet 14 is a biocompatible polymer stronger than polycaprolactone, for example, a biodegradable polymer such as chitin, chitosan, polylactic acid, or polyglycolic acid, and chitin is among them. is preferred.
- the fiber diameter of the microfibers of the reinforcing sheet 14 is preferably larger than that of the microfibers of the cell retention sheet 12.
- the stem cells may be attached to the reinforcing sheet 14 in the step of attaching the stem cells to the cell holding sheet 12.
- the above is the configuration of the tissue regeneration promoting sheet 10.
- the cell holding sheet 12 and reinforcing sheet 14, which are stacked on each other, are set between a pair of holders 20 that constitute a filtration device.
- Each holder 20 is configured to allow the cell suspension to flow out or flow in, and when the cell suspension flows from one holder 20 to the other holder 20, the cell suspension comes into contact with the cell holding sheet 12.
- a cell suspension containing stem cells is slowly dropped one drop at a time from above, and the cell suspension is filtered through two cell holding sheets 12.
- the filtration rate is, for example, the rate at which 1 ml of the cell suspension is dropped over 2 to 3 minutes.
- the stem cells contained in the dropped cell suspension attach themselves to the fibers of the cell holding sheet 12.
- the exact mechanism is unknown, when a cell suspension containing stem cells is filtered little by little through a nonwoven fabric made of fibers whose main component is polycaprolactone, the stem cells stably adhere to each fiber, and the adhesion increases. These stem cells are activated and the production of growth factors is promoted.
- the above is a specific procedure for attaching stem cells to the cell holding sheet 12.
- the tissue regeneration promoting sheet 10 includes the cell retaining sheet 12 which includes fibers mainly composed of polycaprolactone and is capable of permeating a cell suspension containing stem cells, A reinforcing sheet 14 is laminated on the holding sheet 12 and is capable of permeating the cell suspension. Therefore, the cell holding sheet 12 can stably hold stem cells and improve handling by the user.
- two cell holding sheets 12 are placed between the pair of reinforcing sheets 14, but the invention is not limited thereto.
- the number of cell holding sheets 12 sandwiched between the pair of reinforcing sheets 14 may be one, or three or more.
- the reinforcing sheet 14 was made of nonwoven fabric, but the present invention is not limited to this.
- the reinforcing sheet 14 may be a porous material that can be permeated with a cell suspension.
- the reinforcing sheet 14 is sandwiched between the cell holding sheet 12 from above and below, but the present invention is not limited to this.
- the tissue regeneration promoting sheet 10 may be constructed by laminating a reinforcing sheet 14 on one side of the cell holding sheet 12. If the strength of the tissue regeneration promoting sheet 10 can be ensured even if the reinforcing sheet 14 is omitted, or if it is unnecessary to ensure the strength of the tissue regeneration promoting sheet 10, the reinforcing sheet 14 may be omitted. There are cases where it is not necessary to ensure the strength of the tissue regeneration promoting sheet 10, for example, when the tissue regeneration promoting sheet 10 is housed in a space within an implant or when it is rolled up and embedded in a damaged area in the body.
- the tissue regeneration promoting sheet 10 is made by laminating a first cell-retaining sheet 12A and a second cell-retaining sheet 12B, which is less deformable than the first cell-retaining sheet 12A.
- the second cell retention sheet 12B may have a larger fiber diameter or a higher fiber density than the first cell retention sheet 12A, for example.
- the first cell retention sheet 12A is an example of a first nonwoven fabric
- the second cell retention sheet 12B is an example of a second nonwoven fabric that is less deformable than the first nonwoven fabric.
- Example 1 a sheet in which a polycaprolactone (PCL) nonwoven fabric and a chitin nonwoven fabric were laminated was produced using the method according to the above embodiment, and the capture rate of mesenchymal stem cells in each was evaluated. Specifically, as shown in FIG. 1, two PCL nonwoven fabrics were first sandwiched between chitin nonwoven fabrics from above and below and joined together.
- the PCL nonwoven fabric has a fiber diameter of 0.5 to 1 ⁇ m and a fiber density of 2 g/m 2
- the chitin nonwoven fabric has a fiber diameter of 8 ⁇ m and a fiber density of 30 g/m 2 .
- mesenchymal stem cells were attached to the PCL nonwoven fabric by passing a cell suspension containing human mesenchymal stem cells through a holder for filter sterilization, and the capture rate of mesenchymal stem cells was evaluated.
- a holder a Swinex filter holder (Merck Millipore) was used.
- similar experiments were conducted on sheets made of only two chitin nonwoven fabrics laminated. Experiments were conducted on three samples each.
- the results are shown in Figure 5.
- the average cell capture rate was 43.6% for the sheet made by laminating only chitin nonwoven fabric, whereas the average cell capture rate was 100% for the sheet made by laminating PCL nonwoven fabric and chitin nonwoven fabric. From the above, it was confirmed that the PCL nonwoven fabric allows stem cells to adhere with high efficiency.
- Example 2 In Example 2, a sheet in which a PCL nonwoven fabric and a polyester (PEs) nonwoven fabric were laminated, a sheet made of PCL nonwoven fabric alone, and a sheet in which two PCL nonwoven fabrics with different characteristics were laminated were produced and their handling properties were verified. In addition, a cell suspension was dropped onto each sample, and the cell capture rate was measured.
- PEs polyester
- a sheet was produced in which a PCL nonwoven fabric with a fiber diameter of 0.5 ⁇ m, a fiber density of 2 g/m 2 , and a thickness of 100 ⁇ m was laminated with a PCL nonwoven fabric with a fiber diameter of 4.9 ⁇ m, a fiber density of 10 g/m 2 , and a thickness of 500 ⁇ m.
- this sheet could be set in the holder.
- Other procedures are the same as in Example 1. Experiments were conducted using three samples for each condition, but only one sample was used for sheets with fiber diameter of 0.5 ⁇ m, fiber density of 2 g/m 2 , thickness of 100 ⁇ m, number of PEs stacks of 2, and PCL stacks of 3 to 6. I conducted an experiment.
- Example 3 In Example 3, a sheet in which a PCL nonwoven fabric and a chitin nonwoven fabric were laminated together with bone fragments was transplanted into the cervical vertebrae of three immunodeficiency model rats, and bone fusion was manually evaluated 6 weeks after the transplantation. Bone fusion was also evaluated using CT (Computed Tomography) images of the cervical vertebrae of immunodeficiency model rats and immunostained images of collected tissue pieces. Immunostaining images are obtained by photographing tissue pieces stained with DAPI (4',6-diamidino-2-phenylindole), which is a fluorescent dye that binds to DNA (Deoxyribonucleic acid), using a fluorescence microscope.
- DAPI 4,6-diamidino-2-phenylindole
- a sheet made by laminating PCL nonwoven fabric and chitin nonwoven fabric to which human mesenchymal stem cells were attached was used.
- the tissue regeneration promoting sheet of the present invention is useful because it is capable of stably retaining stem cells.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Sustainable Development (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Developmental Biology & Embryology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Rheumatology (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2023288956A AU2023288956A1 (en) | 2022-06-22 | 2023-06-21 | Tissue regeneration promotion sheet |
| CA3260275A CA3260275A1 (en) | 2022-06-22 | 2023-06-21 | TISSUE REGENERATION PROMOTION SHEET |
| US18/877,261 US20250381316A1 (en) | 2022-06-22 | 2023-06-21 | Tissue regeneration promotion sheet |
| CN202380048274.5A CN119403580A (zh) | 2022-06-22 | 2023-06-21 | 组织再生促进片材 |
| EP23827248.8A EP4545106A4 (en) | 2022-06-22 | 2023-06-21 | Tissue regeneration-promoting film |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022-100731 | 2022-06-22 | ||
| JP2022100731 | 2022-06-22 | ||
| JP2023-054932 | 2023-03-30 | ||
| JP2023054932A JP7502751B2 (ja) | 2022-06-22 | 2023-03-30 | 組織再生促進シート |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023249065A1 true WO2023249065A1 (ja) | 2023-12-28 |
Family
ID=89380057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2023/022993 Ceased WO2023249065A1 (ja) | 2022-06-22 | 2023-06-21 | 組織再生促進シート |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250381316A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4545106A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024101015A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119403580A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023288956A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3260275A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023249065A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120960508A (zh) * | 2025-09-30 | 2025-11-18 | 以诺康医疗科技(合肥)有限公司 | 一种高载量抗菌可吸收补片及其制备方法和应用 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008516819A (ja) * | 2004-10-20 | 2008-05-22 | エシコン・インコーポレイテッド | 医療器具用の強化された吸収性複層布およびその製造方法 |
| JP4847129B2 (ja) | 2003-06-06 | 2011-12-28 | 旭化成クラレメディカル株式会社 | 創傷治癒促進材 |
| JP2013523225A (ja) * | 2010-03-30 | 2013-06-17 | 3ティー テクスティルテクノロギートランスファー ゲーエムベーハー | サンドイッチ構造、インプラントシステム及び支持担体を備えるインプラント |
| JP2014527435A (ja) * | 2011-08-09 | 2014-10-16 | ニュー ジャージー インスティチュート オブ テクノロジー | 骨修復適用のための複合材料マトリックス |
| JP2015112262A (ja) | 2013-12-11 | 2015-06-22 | 学校法人藤田学園 | 組織修復及び/又は再生促進材 |
| JP2022100731A (ja) | 2020-12-24 | 2022-07-06 | 株式会社エンターライズ | 遊技機 |
| JP2023047494A (ja) * | 2021-09-27 | 2023-04-06 | 学校法人藤田学園 | 骨修復デバイス及び手術用キット |
| JP2023054932A (ja) | 2021-10-05 | 2023-04-17 | 東芝エネルギーシステムズ株式会社 | 回転ガントリーの整線装置、回転ガントリーの整線方法および粒子線治療システム |
-
2023
- 2023-06-21 CA CA3260275A patent/CA3260275A1/en active Pending
- 2023-06-21 CN CN202380048274.5A patent/CN119403580A/zh not_active Withdrawn
- 2023-06-21 EP EP23827248.8A patent/EP4545106A4/en active Pending
- 2023-06-21 WO PCT/JP2023/022993 patent/WO2023249065A1/ja not_active Ceased
- 2023-06-21 US US18/877,261 patent/US20250381316A1/en active Pending
- 2023-06-21 AU AU2023288956A patent/AU2023288956A1/en not_active Withdrawn
-
2024
- 2024-05-29 JP JP2024086757A patent/JP2024101015A/ja active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4847129B2 (ja) | 2003-06-06 | 2011-12-28 | 旭化成クラレメディカル株式会社 | 創傷治癒促進材 |
| JP2008516819A (ja) * | 2004-10-20 | 2008-05-22 | エシコン・インコーポレイテッド | 医療器具用の強化された吸収性複層布およびその製造方法 |
| JP2013523225A (ja) * | 2010-03-30 | 2013-06-17 | 3ティー テクスティルテクノロギートランスファー ゲーエムベーハー | サンドイッチ構造、インプラントシステム及び支持担体を備えるインプラント |
| JP2014527435A (ja) * | 2011-08-09 | 2014-10-16 | ニュー ジャージー インスティチュート オブ テクノロジー | 骨修復適用のための複合材料マトリックス |
| JP2015112262A (ja) | 2013-12-11 | 2015-06-22 | 学校法人藤田学園 | 組織修復及び/又は再生促進材 |
| JP2022100731A (ja) | 2020-12-24 | 2022-07-06 | 株式会社エンターライズ | 遊技機 |
| JP2023047494A (ja) * | 2021-09-27 | 2023-04-06 | 学校法人藤田学園 | 骨修復デバイス及び手術用キット |
| JP2023054932A (ja) | 2021-10-05 | 2023-04-17 | 東芝エネルギーシステムズ株式会社 | 回転ガントリーの整線装置、回転ガントリーの整線方法および粒子線治療システム |
Non-Patent Citations (7)
| Title |
|---|
| ERICA J. LEVORSON, MARCO SANTORO, F. KURTIS KASPER, ANTONIOS G. MIKOS: "Direct and indirect co-culture of chondrocytes and mesenchymal stem cells for the generation of polymer/extracellular matrix hybrid constructs", ACTA BIOMATERIALIA, ELSEVIER, AMSTERDAM, NL, vol. 10, no. 5, 1 May 2014 (2014-05-01), AMSTERDAM, NL, pages 1824 - 1835, XP055552064, ISSN: 1742-7061, DOI: 10.1016/j.actbio.2013.12.026 * |
| HEATHER E. OWSTON; KATRINA M. MOISLEY; GIUSEPPE TRONCI; STEPHEN J. RUSSELL; PETER V. GIANNOUDIS; ELENA JONES: "Induced Periosteum-Mimicking Membrane with Cell Barrier and Multipotential Stromal Cell (MSC) Homing Functionalities", ARXIV.ORG, CORNELL UNIVERSITY LIBRARY, 201 OLIN LIBRARY CORNELL UNIVERSITY ITHACA, NY 14853, 5 January 2021 (2021-01-05), 201 Olin Library Cornell University Ithaca, NY 14853 , XP081853130, DOI: 10.3390/ijms21155233 * |
| JABUR AKRAM R.; AL-HASSANI EMAD S.; AL-SHAMMARI AHMED M.; NAJIM MANAR A.; HASSAN AYMEN A.; AHMED AESAR A.: "Evaluation of Stem Cells’ Growth on Electrospun Polycaprolactone (PCL) Scaffolds Used for Soft Tissue Applications", ENERGY PROCEDIA, ELSEVIER, NL, vol. 119, 4 September 2017 (2017-09-04), NL , pages 61 - 71, XP085168231, ISSN: 1876-6102, DOI: 10.1016/j.egypro.2017.07.048 * |
| LABBAF S., HOUREH A. BAHARLOU, RAHIMI M., TING HUNG-KAI, JONES JR., NASR-ESFAHANI MH: "Bioactive glass-polycaprolactone fiber membrane and response of dental pulp stem cells in vitro", BIOMEDICAL GLASSES, vol. 4, no. 1, 1 December 2018 (2018-12-01), pages 123 - 130, XP093121132, ISSN: 2299-3932, DOI: 10.1515/bglass-2018-0011 * |
| NISBET D. R., YU L. M. Y., ZAHIR T., FORSYTHE J. S., SHOICHET M. S.: "Characterization of neural stem cells on electrospun poly(ε-caprolactone) submicron scaffolds: evaluating their potential in neural tissue engineering", JOURNAL OF BIOMATERIALS SCIENCE. POLYMER EDITION., VSP, UTRECHT., NL, vol. 19, no. 5, 1 January 2008 (2008-01-01), NL , pages 623 - 634, XP093121133, ISSN: 0920-5063, DOI: 10.1163/156856208784089652 * |
| PAIM ÁGATA; TESSARO ISABEL C.; CARDOZO NILO S.; PRANKE PATRICIA: "Mesenchymal stem cell cultivation in electrospun scaffolds: mechanistic modeling for tissue engineering", JOURNAL OF BIOLOGICAL PHYSICS., KLUWER ACADEMIC PUBLISHERS, DORDRECHT., NL, vol. 44, no. 3, 5 March 2018 (2018-03-05), NL , pages 245 - 271, XP036564286, ISSN: 0092-0606, DOI: 10.1007/s10867-018-9482-y * |
| RUSSO VALENTINA; TAMMARO LOREDANA; DI MARCANTONIO LISA; SORRENTINO ANDREA; ANCORA MASSIMO; VALBONETTI LUCA; TURRIANI MAURA; MARTEL: "Amniotic epithelial stem cell biocompatibility for electrospun poly(lactide-co-glycolide), poly(ε-caprolactone), poly(lactic acid) scaffolds", MATERIALS SCIENCE AND ENGINEERING C, ELSEVIER SCIENCE S.A., CH, vol. 69, 1 July 2016 (2016-07-01), CH , pages 321 - 329, XP029724955, ISSN: 0928-4931, DOI: 10.1016/j.msec.2016.06.092 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN119403580A (zh) | 2025-02-07 |
| CA3260275A1 (en) | 2025-04-01 |
| EP4545106A4 (en) | 2025-10-15 |
| JP2024101015A (ja) | 2024-07-26 |
| EP4545106A1 (en) | 2025-04-30 |
| AU2023288956A1 (en) | 2025-01-16 |
| US20250381316A1 (en) | 2025-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Aldemir Dikici et al. | A novel bilayer polycaprolactone membrane for guided bone regeneration: combining electrospinning and emulsion templating | |
| Fujimoto et al. | An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction | |
| US12472057B2 (en) | Tubular prostheses | |
| JPH11267193A (ja) | バイオハイブリッド型関節表面置換物 | |
| WO2018050092A1 (zh) | 人工组织前体及制备其的方法 | |
| JP4847129B2 (ja) | 創傷治癒促進材 | |
| KR101293209B1 (ko) | 조직 재생 유도 구조물 | |
| JP2007325543A (ja) | 細胞足場材料およびその製造方法 | |
| JP2024101015A (ja) | 組織再生促進シート | |
| TW201945539A (zh) | 生物體移植用細胞片及其製造方法 | |
| US20260000812A1 (en) | Novel porous scaffold and method for manufacturing same | |
| JP7502751B2 (ja) | 組織再生促進シート | |
| Prévôt et al. | From biomaterial, biomimetic, and polymer to biodegradable and biocompatible liquid crystal elastomer cell scaffolds | |
| WO2007005828A2 (en) | Cell growth and cell transplant devices for gene therapy | |
| KR102364686B1 (ko) | 신규한 다공성 스캐폴드 및 이의 제조방법 | |
| JP7555082B1 (ja) | 幹細胞付着用シート | |
| Wu et al. | Chitosan/alginate multilayer scaffold encapsulating bone marrow stromal cells in situ on titanium | |
| JP2004267562A (ja) | 生体用担体及び細胞培養方法 | |
| Wang et al. | Nanofibrous electrospun barrier membrane promotes osteogenic differentiation of human mesenchymal stem cells | |
| Niu et al. | Making a Hydrophilic Interfacial Scaffold with Hierarchical Nanofibre Architecture to Enhance the Phenotypic Expression of Epithelial and Smooth Muscle Cells for Urethral Reconstruction | |
| Bit et al. | Biomaterials for a synthetic and tissue engineered blood vessel | |
| Perko | Applying Mesenchymal Stromal Cells and Platelet-Rich Plasma on a Collagen Matrix to Improve Fascial Repair | |
| Toyoshima | Biomaterial Research in Japan | |
| Browning | Development of Multilayer Vascular Grafts Based on Collagen-Mimetic Hydrogels | |
| Zhang et al. | SymbolFabrication of a tubular vascular scaffold with circumferential microchannels to induce oriented growth of smooth muscle cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23827248 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202380048274.5 Country of ref document: CN Ref document number: 18877261 Country of ref document: US |
|
| WWE | Wipo information: entry into national phase |
Ref document number: AU2023288956 Country of ref document: AU |
|
| ENP | Entry into the national phase |
Ref document number: 2023288956 Country of ref document: AU Date of ref document: 20230621 Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2023827248 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2023827248 Country of ref document: EP Effective date: 20250122 |
|
| WWP | Wipo information: published in national office |
Ref document number: 202380048274.5 Country of ref document: CN |
|
| WWP | Wipo information: published in national office |
Ref document number: 2023827248 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 18877261 Country of ref document: US |